Konstantinos Marmagkiolis, MD, on TAVR's New Frontier

Few developments in modern cardiology have transformed patient care as rapidly as transcatheter aortic valve replacement (TAVR). What began as a last-resort option for patients considered too frail for open-heart surgery has evolved into a mainstream treatment used across a growing range of clinical situations.  

Interventional cardiologist Konstantinos Marmagkiolis, MD, has seen that evolution firsthand in the catheterization lab, where the conversation around severe aortic stenosis has shifted from whether a patient can withstand surgery to which minimally invasive approach best suits their needs.

Aortic stenosis, the progressive narrowing of the valve that controls blood flow from the heart, was once viewed as an unavoidable consequence of aging that many patients simply could not survive having corrected. That outlook has changed. 

As technology has advanced and clinical evidence has grown, TAVR has steadily expanded to patients across the risk spectrum, reshaping who can benefit from treatment.

Image Source: Unsplashed

From Inoperable Patients to Everyday Practice

When TAVR first entered clinical practice, it was reserved for patients with virtually no other treatment option. These were individuals whose age, lung disease, previous surgeries, or overall frailty made open-heart surgery prohibitively risky. For them, the choice often came down to a novel catheter-based valve replacement or a gradual decline. Early clinical trials demonstrated that the procedure not only offered a less invasive alternative but also significantly improved survival compared with medical therapy alone. 

That success led to a series of additional studies. Researchers expanded from high-risk surgical candidates to intermediate-risk patients and, eventually, to lower-risk individuals who previously would have been referred directly for surgery. At each stage, the evidence continued to support broader use. The steady expansion reflects the thoughtful approach to structural heart disease that defines modern interventional cardiology, in which treatment decisions are increasingly tailored to the individual rather than relying on a single standard approach.

The result has been a fundamental shift in the management of aortic stenosis. A diagnosis that once prompted difficult conversations about whether treatment was even possible now opens the door to multiple options. Heart teams consider anatomy, age, life expectancy, valve durability, and patient preferences, with minimally invasive treatment becoming the preferred option for a growing number of patients.

Why the Indications Keep Widening

Several factors continue to drive that expansion.

The first is advances in device technology. Newer valve designs fit more precisely, reduce leakage around the valve, and are available in a wider range of sizes, allowing physicians to treat anatomies that earlier devices could not accommodate. Improvements in delivery systems have also made procedures faster, more predictable, and associated with fewer complications.

The second is growing clinical experience. As medical centers perform more TAVR procedures, outcomes continue to improve, and the learning curve becomes less steep. Procedures that once required general anesthesia and intensive care are now frequently performed using conscious sedation, with many patients returning home within one or two days. This move toward streamlined, minimally invasive valve therapy has made TAVR a practical option for patients who want to avoid a lengthy recovery and return to their normal routines sooner.

The third factor is the growing body of clinical evidence. Long-term follow-up from the landmark clinical trials has begun to answer questions about valve durability that once made some physicians hesitant to recommend TAVR for younger patients. The concern was that transcatheter valves might not last as long as surgically implanted valves, potentially requiring additional procedures later in life. The accumulating evidence has been reassuring, providing clinicians with a much clearer understanding of long-term valve performance. Physicians who follow the growing body of clinical trial data can now counsel patients with far greater confidence than was possible only a few years ago.

New Populations Entering the Conversation

The expansion of TAVR is no longer limited to traditional surgical risk categories. Attention has increasingly turned to patient populations that were once considered poor candidates or excluded from early studies.

Bicuspid aortic valve disease, a congenital condition in which the valve has two leaflets instead of three, was historically viewed as a difficult anatomy for TAVR. Improvements in imaging and increased procedural experience have made treatment possible for many of these patients, opening new options for younger individuals who often develop aortic stenosis earlier in life.

Patients with failing surgical bioprosthetic valves represent another important area of growth. Rather than undergoing a second open-heart operation to replace a worn-out tissue valve, many patients can now receive a transcatheter valve placed within the existing prosthesis, reducing the risks associated with repeat surgery. 

This approach reflects a broader trend in interventional cardiology and structural heart care toward treating increasingly complex conditions through the least invasive option available.

There is also growing interest in whether patients with moderate aortic stenosis, or those with severe disease who have not yet developed symptoms, may benefit from earlier intervention. Traditional practice has favored waiting until symptoms appear before recommending valve replacement. 

However, emerging evidence suggests that damage to the heart muscle may begin before patients notice symptoms. If ongoing clinical trials demonstrate a clear benefit to earlier treatment, the number of patients eligible for TAVR could expand significantly.

 What This Means for Patients

For patients, the practical impact of these advances is significant. A diagnosis of severe aortic stenosis no longer carries the same sense of uncertainty it once did. Many people who might have been considered too high-risk for treatment a decade ago can now undergo a procedure that allows them to return to normal activities within days rather than facing a lengthy surgical recovery.

That does not mean TAVR is the right choice for every patient. Surgical valve replacement remains the preferred approach for certain anatomies and some younger individuals, and treatment decisions should be made by a multidisciplinary heart team that evaluates the complete clinical picture. 

Physicians who emphasize shared decision-making and individualized care, an approach reflected in the professional work and clinical philosophy of experienced structural heart specialists, are often best positioned to match each patient with the treatment option most appropriate for their needs.

The role of the interventional cardiologist has expanded alongside these technological advances. Today’s specialists must be skilled in advanced imaging, valve selection, procedural planning, and the management of complications that may occur during or after treatment. The training and continued education required to support this growing field of structural heart care are extensive, which is why the specialty continues to attract physicians committed to advancing cardiovascular medicine.

 Looking Ahead

The evolution of TAVR is far from complete. Researchers continue to study valve-in-valve procedures, develop strategies for more complex anatomies, and evaluate whether earlier intervention can improve long-term heart function. Device manufacturers continue to refine valve technology, and each new generation has the potential to expand treatment options for additional patient groups.

For clinicians like Konstantinos Marmagkiolis, MD, the most remarkable part of TAVR’s evolution is how dramatically the field has changed. A therapy that was once limited to the sickest and most fragile patients has become a central component of aortic stenosis treatment across the risk spectrum.

The expanding role of TAVR represents more than a technological achievement. It reflects a broader transformation in cardiovascular care, in which treatment decisions are increasingly personalized, and patients who once had few options now have meaningful alternatives.

As research continues and technology advances, aortic stenosis is being redefined from a condition patients simply endure to one that can be effectively treated and managed. That progress, built on years of careful investigation and growing clinical experience, stands as one of the most important developments in modern cardiovascular medicine.

This is a guest blog entry.

Is facial plastic surgery healthy?

When it comes to your face, understanding the risks, benefits, and what really matters is as important as ever. With so many options when it comes to cosmetic procedures, there’s a lot to consider. And with facial plastic surgery, a simple question that doesn’t have a simple answer: Is it healthy?

For some, it’s a way to feel more confident and aligned with how they see themselves. For others, it raises concerns about safety, long-term effects, or whether it’s even a good idea in the first place. The truth is, it depends on how you define “healthy” and how the decision is made.

What does “healthy” mean here?

When people ask this question, they’re usually thinking about two things. Physical safety and emotional impact.

From a medical standpoint, facial plastic surgery is considered safe when performed by a qualified, experienced surgeon in an appropriate setting. Procedures like facelifts, rhinoplasty, and eyelid surgery have been refined over decades, and techniques continue to improve. Like any surgery, there are risks of course. These can include infection, scarring, or complications related to anesthesia. In some cases, procedures can be exceptionally complicated and best performed by an experienced facial plastic surgeon who can use their know how to bring out the best in natural results. For example, one procedure that’s becoming increasingly in demand is the deep plane facelift which typically requires a high degree of sophistication to have the best possible outcome. With that said, and assuming your chosen surgeon is highly experienced and is known for excellent results, for most healthy individuals, these risks are relatively low, especially when proper screening and planning are involved.

How safe are facial procedures today?

 Modern facial plastic surgery is far more precise than it used to be. Surgeons now focus on preserving natural structure and creating subtle, natural results rather than dramatic changes.

Advances in technique, anesthesia, and recovery care have made procedures more predictable and often easier to recover from. Still, safety depends heavily on the surgeon’s experience, the patient’s health, and realistic expectations going in.

Can it be good for your well-being?

Health is not just physical. For many people, how they feel about their appearance has a direct impact on confidence and day-to-day life.

When someone chooses facial plastic surgery for personal reasons, and with a clear understanding of the outcome, the experience can be positive. Many people report feeling more comfortable, more confident, and more like themselves.

That said, surgery is not a solution for deeper emotional struggles. If expectations are unrealistic or tied to outside pressure, the results are less likely to feel satisfying.

When might it not be a good idea?
Facial plastic surgery is not the right choice for everyone.

Certain health conditions can increase risk. Some people may not heal well while others may be looking for a level of change that surgery cannot realistically deliver.

There is also the influence of social media and edited images, which often creates expectations that don’t match real-world results. A responsible approach always starts with a clear, honest conversation about what is possible.

What about non-surgical options?

 Not every concern requires surgery. Treatments like injectables, skin resurfacing, and other non-surgical approaches can improve certain aspects of appearance with less downtime.

These options can be a good starting point, although they tend to be temporary and may not address deeper structural changes.

So, is facial plastic surgery healthy?

It can be.

When done for the right reasons, by the right professional, and with realistic expectations, facial plastic surgery can be a safe and reasonable choice. It’s about making adjustments that help your appearance better reflect how you feel.

Cosmetic Beauty Techniques

As techniques continue to improve, facial plastic surgery is becoming more refined and more natural in its results. For many people, the goal is simple. That is, to look rested and comfortable in their own skin.

This is an article by John Summers.

Gabriel Carabello Discusses Peripheral Arterial Disease: When Circulation Becomes a Challenge

Image source: Unsplash

According to Gabriel Carabello, Peripheral Arterial Disease (PAD) affects millions of people worldwide, often going unnoticed until symptoms become more severe. The condition arises when arteries narrow due to plaque buildup, limiting blood flow to the limbs—typically the legs. 

Understanding the risk factors, recognizing the symptoms, and knowing when to seek help are crucial for effectively managing PAD. Lifestyle changes, medical management, and sometimes surgical intervention all play a role in improving circulation and quality of life. With the right care, many individuals with PAD can lead active, healthy lives while reducing the risk of heart-related issues.

Although PAD is relatively common, it develops slowly and may not be noticed right away. Many people go undiagnosed until symptoms become more noticeable or complications arise. Reduced blood supply due to PAD can also delay healing in minor injuries, potentially leading to more serious issues if left unaddressed. In more severe cases, untreated PAD can result in tissue damage or even amputation.

Causes and Risk Factors

The most common cause of PAD is atherosclerosis, a condition in which fatty deposits build up along arterial walls. This buildup narrows the arteries and limits the amount of oxygen-rich blood reaching the limbs. Over time, this restricted flow can damage tissues and increase the risk of a heart attack or stroke. Inflammatory conditions and certain infections can also contribute to arterial narrowing.

Certain lifestyle choices and health conditions raise the risk of developing PAD. People who smoke, have diabetes, or struggle with high blood pressure or elevated cholesterol levels are more likely to develop the disease. Age also plays a role, particularly in individuals over 60, and a family history of vascular disease can further increase susceptibility. Men are slightly more prone to PAD, though women may experience more severe symptoms once diagnosed. 

Recognizing the Warning Signs

One of the earliest and most telling signs of PAD is leg discomfort during physical activity, which often disappears with rest. This symptom, known as claudication, may feel like cramping, heaviness, or fatigue in one or both legs. Some individuals notice their feet feel colder than usual or observe a change in skin color. Tingling or numbness in the lower limbs may also occur, especially in cooler temperatures.

In more advanced stages, people may experience slow-healing wounds on their feet or toes. These sores are often overlooked until they become painful or infected. In some cases, PAD remains silent, with no noticeable symptoms until serious complications appear. Regular attention to these subtle changes in the body can play a crucial role in early detection.

How PAD Is Diagnosed

Doctors begin by evaluating symptoms and medical history, but a key screening tool is the ankle-brachial index, or ABI. This simple, non-invasive test compares ankle and arm blood pressure to detect reduced circulation. A lower reading in the legs often indicates PAD. This test is widely available and can be conducted in most primary care settings.

When more clarity is needed, imaging techniques such as Doppler ultrasound or magnetic resonance angiography can help map the blood flow and pinpoint blockages. These tests not only confirm the diagnosis but also guide treatment by revealing the severity of the narrowing. Identifying PAD early can make a significant difference in managing symptoms and preventing complications.

Treatment Approaches

 Managing PAD starts with lifestyle changes that support healthier blood vessels. Quitting smoking is often the first recommendation, as tobacco use significantly worsens arterial damage. A diet focused on whole grains, lean proteins, and healthy fats can also reduce blood pressure and cholesterol, both of which contribute to atherosclerosis. Regular physical activity, like supervised walking programs, is encouraged to improve circulation over time.

In some cases, medications that thin the blood or control blood sugar are necessary to prevent clots and slow disease progression. When symptoms persist despite other measures, procedures like angioplasty may be used to open blocked arteries. Surgery, such as bypass grafting, is typically reserved for severe cases where circulation is critically impaired.

Daily Life and When to Get Help

 Living with PAD means staying alert to changes in your body and maintaining regular contact with a healthcare provider. Simple habits like checking the feet for cuts or blisters, walking daily to improve circulation, and keeping chronic conditions under control can go a long way toward managing PAD.

Persistent leg pain at rest, open sores that won’t heal, or a sudden drop in limb temperature may signal a serious decline in blood flow. These signs shouldn’t be ignored and require immediate medical attention. By staying proactive and informed, many with PAD are able to maintain a good quality of life.

This is a guest blog entry.